CorMedix 2.0: New Leadership, New Approval, New Focus

Editor's note: Seeking Alpha is proud to welcome Sergio Gonzalez as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access. I am a corporate strategy professional with work experience across industrials, energy, and technology. My primary investment interest is in biotech where I have over a decade of investment experience. My secondary investment interests are ...